Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absolute, Acorda, Actemra, Activella, ahead, AMAG, Amarillo, Amerisource, Argentina, austerity, Avanir, Baylor, believevitaMedMDVitamin, Bergen, Biology, blockbuster, Boniva, bothersome, Brigham, Cadence, caption, carryforward, chose, commodity, compensatory, Conbriza, conceived, conceptualized, culminating, cytology, Dendreon, Detrol, Donegan, Duavee, Dyax, easier, Endocrinology, Ernst, euro, Europe, Eurozone, EvaluatePharma, faculty, fell, fellowship, Floor, FOLMAX, forfeit, forfeitable, Frontier, GBI, George, graph, Greenberg, Halozyme, Hamilton, ibandronate, illiquidity, immaterial, incomplete, incremental, inferring, inIssuance, injectable, Intarcia, irritation, itching, Japan, Joel, Kilpatrick, Krasnow, Lipitor, Luce, Lybrel, margin, Marlan, meant, Michael, Mirkin, Molecular, musculoskeletal, nonrefundable, Nordisk, Norfolk, Novo, ofFinancial, onset, Orexigen, Organon, oversaw, paper, patch, pearl, Pfizer, pH, Pittsburgh, Plavix, Preview, prime, productsprimarily, reinvestment, Roche, RSU, Sandra, SCI, Sebastian, seeWarrant, sensitivity, Sensormatic, simple, sodium, speculative, SPRY, Stifel, Stockton, straight, symptom, tartrate, tiny, tocilizumab, tolterodine, Townsend, Traurig, Tyco, underwriting, unprecedented, unvested, urination, USA, user, Vagifem, Valeant, Virginia, vitaMedMDOne, vitaMedMDRediChew, vitaMedMDRediChew™Rx, vitaPearl, VVA, Walker, weak, Young, zoledronic, Zometa
Removed:
accountant, aggregated, assignment, billed, classification, communicate, consummation, deposit, directorship, encumbrance, EVA, founded, goodwill, herewith, indirect, installation, LTIP, men, mentioned, opportunity, outlined, owner, percent, principle, purpose, realization, restated, segment, seller, sixty, spent, triangulated, trust
Filing tables
Filing exhibits
- 10-K Annual report
- 23.1 Consent of Rosenberg Rich Baker Berman & Co.
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Section 1350 Certification of Chief Executive Officer
- 32.2 Section 1350 Certification of Chief Financial Officer
- Download Excel data file
- View Excel data file
Related press release
TXMD similar filings
Filing view
External links
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-185156, 333-186189, 333-193558) on Form S-3 and (No. 333-191730) on Form S-8 of TherapeuticsMD, Inc. of our report dated March 5, 2014, relating to our audits of the consolidated financial statements as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013, and the effectiveness of internal control over financial reporting as of December 31, 2013, which appear in the Annual Report on Form 10-K of TherapeuticsMD, Inc. for the year ended December 31, 2013.
/s/ Rosenberg Rich Baker Berman & Company
Somerset, NJ
March 5, 2014